-
| Sector | Healthcare |
|---|---|
| Industry | Biotechnology |
| Exchange | LSE |
| CurrencyCode | GBP |
| ISIN | GB00BMCLYF79 |
| Beta | 1.06 |
|---|---|
| Market Cap | 174M |
| PE Ratio | None |
| Target Price | 1700 |
| Dividend Yield | None |
4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company offers AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. It also offers access to its targeted non-viral delivery platform, Hermes. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4BB.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025